Treatment of alcohol withdrawal
54 results
1 - 54
Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Benzodiazepines for alcohol withdrawal
- Anticonvulsants for alcohol withdrawal
- Magnesium for alcohol withdrawal: Cochrane systematic review
- Baclofen for alcohol withdrawal
- Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
- Pharmacotherapy for anxiety and comorbid alcohol use disorders
- Benzodiazepines for delirium
- Anticonvulsants for alcohol dependence: Cochrane systematic review
- Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
- Home visits during pregnancy and after birth for women with an alcohol or drug problem
- Perioperative alcohol cessation intervention for postoperative complications
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Eszopiclone for insomnia: Cochrane systematic review
- Music therapy for people with substance use disorders
- Alpha 2 -adrenergic agonists for the management of opioid withdrawal: Cochrane systematic review
- Interventions for preventing infectious complications in haemodialysis patients with central venous catheters
- Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit
- Benzodiazepines for schizophrenia: Cochrane systematic review
- Lifestyle changes for treating psoriasis
- Lifestyle interventions for chronic gout
- Intra-articular glucocorticoids for acute gout: Cochrane systematic review
- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
- Slow-release oral morphine as maintenance therapy for opioid dependence: Cochrane systematic review
- Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
- Plugs for containing faecal incontinence
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
- Interventions for tophi in gout
- Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation
- Herbal medicinal products or preparations for neuropathic pain
- Maintenance agonist treatments for opiate‐dependent pregnant women
- Psychosocial interventions for benzodiazepine harmful use, abuse or dependence